IBD's rating system evaluates stock performance on a scale of 1 to 99. Stocks with RS Ratings above 80 often lead to significant gains. Calumet is forming a consolidation pattern with a 25.29 buy point. Check if the stock breaks out with strong volume.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing